Novo Nordisk | NVO - 판매 매출 총 이익

주가
36.83
매일 변경
-0.20 -0.54%
매월
-7.07%
매년
-52.07%
Q1 예상
34.66




판매 매출 총 이익 변화 날짜
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Aurora Cannabis CAD 46.62M 14.33M 2025-12
Bausch Health Companies USD 1.93B 165M 2025-09
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Canopy Growth CAD 21.47M 434K 2025-12
Corcept Therapeutics USD 199.58M 3.46M 2025-12
Drreddys Laboratories INR 46.81B 10.24B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
GlaxoSmithKline GBP 6.18B 106M 2025-12
Merck USD 13.42B 431M 2025-09
Nektar Therapeutics USD 13.75M 650K 2024-06
Novartis USD 10.25B 570M 2025-12
Novo Nordisk DKK 64.01B 1.19B 2025-06
Novo Nordisk DKK 64.01B 1.19B 2025-06
Pacira USD 142.25M 11.34M 2025-12
Perrigo USD 362.2M 14.9M 2025-12
Phibro Animal Health USD 133.5M 12.6M 2025-12
Prestige Brands USD 157.37M 5.79M 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Supernus Pharmaceuticals USD 164.04M 15.23M 2025-12
Zoetis USD 1.64B 73M 2025-12